79299814 - TMEXPLORE

Information

  • Trademark
  • 79299814
  • Serial Number
    79299814
  • Registration Number
    6481164
  • Filing Date
    October 01, 2020
    4 years ago
  • Registration Date
    September 14, 2021
    3 years ago
  • Transaction Date
    April 10, 2022
    2 years ago
  • Status Date
    September 14, 2021
    3 years ago
  • Published for Opposition Date
    June 29, 2021
    3 years ago
  • Location Date
    September 14, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SPRUILL, DARRYL M
  • Attorney Docket Number
    BDL-T004XX
    Attorney Name
    Stanley M. Schurgin
    Law Office Assigned Location Code
    M30
  • Owners
Mark Drawing Code
4000
Mark Identification
TMEXPLORE
Case File Statements
  • PM0001: TM EXPLORE
  • GS0441: Medical analysis services relating to the clinical diagnostic and ongoing evaluation, analysis and study of a cancer or tumor microenvironment; medical assistance; health services namely health assessment services; pharmaceutical compound evaluation services; therapeutic services in the field of oncology diagnosis; medical diagnostics, diagnostics in the field of medicine; genetic and/or tissue analysis services for medical purposes; medical testing services for diagnostic or treatment purposes; medical services for the detection, qualification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis
  • GS0421: Research, development, technical design and scientific testing services in the field of oncology; research and development of new products for third parties in the pharmaceutical field; industrial analysis and research services in the field of oncology; biomarker analysis services for pharmaceutical research purposes; microbiological testing services for medical and scientific research; testing biomarkers for clinical trials; tests in laboratories namely testing of cancer related biomarkers; laboratory research services concerning pharmaceutical products; development of testing methods namely development of testing specifications and procedures for the characterization of tumors and tumor microenvironment; research, development, technical design, testing, analysis services and consultation services related thereto in the fields of immunology and oncology; Research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the fields of biomarker analysis, immune repertoire analysis, tissue and genome analysis; design and development of software in the field of biology
Case File Event Statements
  • 4/10/2022 - 2 years ago
    22 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 3/4/2022 - 2 years ago
    21 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS
  • 3/4/2022 - 2 years ago
    20 - GENERIC MADRID TRANSACTION CREATED Type: XXCR
  • 2/12/2022 - 2 years ago
    19 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 12/14/2021 - 3 years ago
    18 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 9/14/2021 - 3 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/29/2021 - 3 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/29/2021 - 3 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/9/2021 - 3 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/23/2021 - 3 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/5/2021 - 3 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/4/2021 - 3 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/4/2021 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/5/2021 - 3 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/18/2021 - 3 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/17/2021 - 3 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/13/2021 - 3 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/12/2021 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/26/2021 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/18/2020 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/14/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/11/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR